TERT and central nervous system cancer: NGS analysis detected TERT promoter mutations in 33 out of 45 investigated gliomas (72.7%), 12 of which harbored the hot-spot C250T (c.1-146C>T) mutation and 21 carrying the C228T (c.1-124C>T) variant.